1 2 7 5 a r t I C l e S Remodeling of central neural circuits depends on the bidirectional control of synapse stability, structure and strength. Synapse stabilization, enlargement and potentiation contribute to the establishment of long-lasting synaptic connections. On the other hand, recent imaging studies have suggested that a fraction of spines become thin and small, and display increased motility and turnover 1 . Such spines have reduced AMPA receptor (AMPAR) content and form weaker synapses 2 ; spine shrinkage is associated with depressed glutamatergic transmission 3, 4 . Synaptic dynamic remodeling therefore contributes to neural circuit development and to the experience-dependent refinement and plasticity of brain circuits during critical periods 5 and throughout life 1 . Conversely, abnormal synapse remodeling underlies many neuropathologies 6 . However, the mechanisms that actively promote coordinated spine shrinkage, increased motility and turnover, and synaptic depression, without leading to synapse elimination, collectively referred to here as destabilization, are not well understood 7 .
a r t I C l e S
Remodeling of central neural circuits depends on the bidirectional control of synapse stability, structure and strength. Synapse stabilization, enlargement and potentiation contribute to the establishment of long-lasting synaptic connections. On the other hand, recent imaging studies have suggested that a fraction of spines become thin and small, and display increased motility and turnover 1 . Such spines have reduced AMPA receptor (AMPAR) content and form weaker synapses 2 ; spine shrinkage is associated with depressed glutamatergic transmission 3, 4 . Synaptic dynamic remodeling therefore contributes to neural circuit development and to the experience-dependent refinement and plasticity of brain circuits during critical periods 5 and throughout life 1 . Conversely, abnormal synapse remodeling underlies many neuropathologies 6 . However, the mechanisms that actively promote coordinated spine shrinkage, increased motility and turnover, and synaptic depression, without leading to synapse elimination, collectively referred to here as destabilization, are not well understood 7 .
Epac2 (exchange protein directly activated by cAMP, cAMP-GEFII and RapGEF4) is a signaling protein previously detected in forebrain postsynaptic densities (PSD) 8, 9 . However, its signaling functions in central spiny synapses are not well understood. Epac2 is a GEF for Rap, a Ras-like small GTPase that, in its active form, promotes formation of thin spines and AMPAR endocytosis [10] [11] [12] , and is required for long-term depression (LTD), depotentiation 10, 13 , long-term potentiation (LTP) and spatial memory storage 14 . Two genes, with complementary tissue distributions, encode Epac proteins, EPAC1 (also known as RAPGEF3) and EPAC2. Epac2 is highly enriched in the brain and adrenal glands, whereas Epac1 is expressed in most non-neural tissues and is far less abundant in the adult brain 15 . In addition to other domains, Epac2 contains a Rap-GEF domain and two cAMP-binding domains, only one of which seems to be functional (Fig. 1a) . Binding of cAMP enhances Epac's GEF activity toward Rap 16 . In vitro and in non-neuronal cells, both Epac1 and 2 activate Rap1 and 2 (ref. 16 ). Epac proteins therefore represent a previously unknown class of PKA-independent cAMP targets 15, 16 , linking cAMP signaling to the regulation of small GTPase function in neurons. A screen for candidate genes in the 2q21-33 autism susceptibility region identified rare non-synonymous variants in the EPAC2 gene 17 . These missense mutations segregated with autistic family members and were not present in a large number of unafflicted control individuals. However, it is unknown whether these mutations affect protein function or neuronal phenotypes.
Neuroligins are postsynaptic adhesion molecules that bind to presynaptic neurexins. Neuroligins 3 and 4 (NLGN3 and NLGN4), as well as neurexin1 (NRXN1), have been genetically associated with autism 18 . Neuroligins regulate synapse morphology 19 and the balance between excitatory and inhibitory synapses 20, 21 . However, little is known about postsynaptic signaling by neuroligins.
We examined the functions and regulation of Epac2 in spines. Our data indicate that Epac2 promotes spine shrinkage and enhanced turnover, resulting in synapse structural destabilization without synapse elimination. Epac2 activation also functionally depresses synapses as a result of removal of GluR2/3-containing AMPARs. Furthermore, two disease-associated Epac2 mutations altered a r t I C l e S protein function, synaptic protein distribution and spine morphology, suggesting potential contributions to disease states.
RESULTS

Epac2 participates in postsynaptic protein complexes
Although several studies have reported an enrichment of Epac2 over Epac1 in brain 15, 22 , some uncertainty still persists over this issue. To compare the relative abundances of Epac1 and 2 in cortical pyramidal neurons with largely stable synapses approaching maturity (28 d in vitro, DIV), we performed quantitative PCR analysis of mRNA. We found 32-fold more Epac2 mRNA than Epac1 mRNA in these neurons (Fig. 1b) .
Proteomic studies have detected Epac2 in forebrain postsynaptic densities 8, 9 . To investigate its synaptic localization, we immunostained cultured cortical neurons using an antibody that detects a single protein band of ~110 kDa in rat cerebral cortex (Fig. 1c) . In pyramidal neurons (28 DIV), we detected Epac2 in punctate structures along dendrites ( Fig. 1d) and in the soma, suggesting that Epac2 has a functional role in dendrites. Epac2 colocalized with the synaptic markers bassoon, GluR2/3, PSD-95 and NR1, indicating that it is enriched in excitatory synapses (Fig. 1d,e) . A substantial amount of Epac2 was present in synapses and spines, in addition to other subcellular compartments ( Supplementary Figs. 1 and 2) . Small puncta of Epac2 signal were also detected in axons and colocalized with tau ( Supplementary  Fig. 2 ). Thus, Epac2 may participate in protein complexes with postsynaptic proteins. Epac2 co-immunoprecipitated with the PSD scaffolding protein PSD-95 from rat forebrain homogenates ( Supplementary Fig. 1 ), indicating that they participate in the same postsynaptic protein complexes.
Specific pharmacological activation of Epac2 in neurons
Epac2 is one of two known PKA-independent cAMP targets; binding of cAMP to its C-terminal cAMP-binding domain enhances its GEF activity in vitro and in non-neuronal cells 16 . The cAMP analog 8-(4-chloro-phenylthio)-2′-O-methyladenosine-3′,5′-cyclic monophosphate (8-CPT) specifically activates Epac, but not PKA 16 , and has been extensively used to study Epac function (Supplementary Discussion and Supplementary Fig. 3) .
The 8-CPT concentrations that we used were similar to those used in other cell types and to the concentration required for half-maximal activation of Epac2 16, 23, 24 . Incubation of cultured cortical neurons with 8-CPT induced Rap activation (P < 0.001; Fig. 1f ). Because mature cortical neurons expressed small amounts of Epac1 relative to Epac2 (Fig. 1b) 15 , the effects of 8-CPT on these neurons are mainly a result of Epac2 activation. Incubation with 8-CPT did not cause CREB phosphorylation (Fig. 1g) , a known PKA-dependent target of cAMP 16 , whereas treatment with brain-derived neurotrophic factor (BDNF), a known activator of CREB, phosphorylated CREB. Incubation with 8-CPT enhanced Epac2 dendritic clustering (Supplementary Fig. 3 ). 8-CPT may also activate Rap1 signaling by the direct phosphorylation of Rap1 by PKA or through C3G or PDZ-GEF1 (ref. 25) , but see the Supplementary Results and Supplementary Discussion. a r t I C l e S
Epac2 activates Rap and causes spine shrinkage
To determine whether Epac2 activation stimulates Rap signaling in dendrites in situ, we examined the effect of 8-CPT on the phosphorylation of a known Rap target, B-Raf 25, 26 . 8-CPT incubation significantly increased the amount of dendritic B-Raf that was phosphorylated (P < 0.001; Fig. 1h-j) . This effect was not Ras dependent, as it was not blocked by the Ras inhibitor FTase II ( Supplementary  Fig. 4 ). To confirm that 8-CPT signals through Epac2, we used RNA interference (RNAi) to knockdown endogenous Epac2. We tested the specificity of the RNAi for Epac2 in HEK293 cells and in neurons ( Supplementary Figs. 5 and 6 ). Epac2 knockdown prevented B-Raf phosphorylation in response to 8-CPT treatment ( Fig. 1i-j) , demonstrating Epac2 dependence and specificity. To determine whether activation of endogenous Epac2 caused structural modifications in spines, we incubated mature green fluorescent protein (GFP)-expressing cultured pyramidal neurons (28 DIV) with 8-CPT (50 µM, 1 h). This treatment induced shrinkage of existing spines, as seen by a reduction in average spine area (P < 0.001 Fig. 2a,b) , breadth and breadth/length ratios, without affecting spine linear density (Supplementary Fig. 7 ). Incubation with 8-CPT for 24 h did not affect spine density.
To determine the requirement for Epac2 in basal and 8-CPTinduced spine morphology, we knocked down endogenous Epac2.
Neurons were transfected with Epac2-specific shRNA that coexpressed GFP; in RNAi-expressing neurons, 8-CPT was incapable of inducing spine shrinkage, demonstrating that normal levels of Epac2 expression are required for 8-CPT-dependent spine shrinkage (Fig. 2a,b) . Epac2 knockdown caused an increase in the average basal spine area (P < 0.001). This effect was rescued by overexpression of an Epac2 rescue mutant, in which three silent point mutations were introduced to render it insensitive to RNAi, demonstrating the specificity of the knockdown (Fig. 2a,b) . RNAi knockdown of Epac2 did not affect spine density (Supplementary Fig. 6 ).
The effects of Epac2 activation on spine morphology were specifically dependent on Epac2 Rap-GEF activity, as 8-CPT did not induce spine shrinkage in neurons expressing an Epac2 mutant protein lacking the catalytic portion of the Rap-GEF domain (Epac2-∆GEF; Fig. 2c,d ). These neurons had significantly larger spines than those overexpressing wild-type Epac2 (P < 0.001). The effects of Epac2 activation were occluded by overexpression of dominantnegative Rap1 and Rap2 (Rap1-DN and Rap2-DN; Supplementary  Fig. 7 ). As expected, Epac2 overexpression did not alter spine area (Supplementary Fig. 6 ), as the default state of Epac2 is autoinhibitory and requires activation to activate Rap 16 .
To determine whether 8-CPT affects the morphology of presynaptic terminals, we visualized presynaptic active zones with an antibody Supplementary Fig. 7 ), suggesting that pre-postsynaptic apposition was reduced and synapses were weaker. These effects on spine/bassoon overlap were occluded by Epac2 RNAi (Supplementary Fig. 7 ). Incubation with 8-CPT also caused a reduction in bassoon-immunoreactive cluster size ( Supplementary Fig. 7 ), indicating a potential presynaptic effect. These data provide evidence that Epac2 activation induces shrinkage of spines and reduction of presynaptic contacts and that these effects require Epac2's Rap-GEF activity.
Epac2 activation enhances spine motility
In vivo studies have revealed that smaller and thinner spines, morphologically resembling those induced by Epac2 activation, are very dynamic and undergo rapid remodeling, whereas large spines are stable 1 . To test whether Epac2 activation affects spine motility and turnover, we performed time-lapse imaging of GFP-expressing cortical neurons ( Fig. 2e-g ). As indicated by color-coded and overlaid images taken at three equally separated time points during the imaging session, spines in control neurons were largely unchanged over the imaging period (80 min), undergoing only limited remodeling (morphing). In 8-CPT-treated neurons, extensive spine morphing, motility and turnover were detectable (Fig. 2e) ; spines retracted, formed or were transient (Supplementary Fig. 8 ). Quantification of total spine motility demonstrated a ~62% increase in motility following Epac2 activation (P < 0.001; Fig. 2f ). 8-CPT did not increase spine motility in Epac2-RNAi-expressing neurons, demonstrating that Epac2 is required for 8-CPT-dependent increased spine motility (Supplementary Fig. 8 ). Time-lapse imaging of the same spine before and after 8-CPT perfusion further confirmed Epac2-dependent spine shrinkage (P < 0.01; Fig. 2g,h ). These data indicate that Epac2 activation causes structural destabilization of spines resulting in overall increased motility.
Epac2 activation promotes AMPAR removal from spines
As spine morphology, stability and function are coordinated 2 , Epac2 may also regulate glutamate receptor function in synapses. In cortical neurons, Epac2 co-immunoprecipitated with GluR2/3 AMPAR subunits, but not with GluR1 (Fig. 3a) . We observed substantial colocalization between Epac2 and GluR2/3 in spines and dendrites (Fig. 1d , quantified in Supplementary Fig. 1 ). This interaction places Epac2 in proximity to a subset of AMPARs, potentially allowing for their rapid regulation.
To determine whether GluR2/3 content in spines was altered by Epac2 activation, we measured the integrated intensity of GluR2/3 immunofluorescence signals in individual spines (Fig. 3b,c) . Following 8-CPT treatment, the amount of GluR2/3 was significantly reduced in spines (P < 0.01) and increased in shaft clusters (P < 0.001; Fig. 3b,c) . These effects were specifically dependent on Epac2; RNAimediated knockdown prevented 8-CPT-induced GluR2/3 removal from spines (Fig. 3c) . RNAi expression did not alter the amount of GluR2/3 present in spines, suggesting that Epac2 activation is only involved in GluR2/3 removal from synapses. GluR1 or NR1 cluster intensities were not affected by 8-CPT (Fig. 3d) . Incubation with 8-CPT also resulted in a significant reduction in GluR2/3-bassoon overlap (P < 0.05; Fig. 3e ) and in a trend toward reduced numbers a r t I C l e S of puncta with colocalized GluR2/3 and bassoon ( Supplementary Fig. 7) . Thus, in addition to destabilizing spines, Epac2 activation also removes GluR2/3-containing AMPARs from synapses, potentially leading to weaker synaptic connections.
Epac2 activation depresses excitatory transmission
To determine the functional outcome of this reduction in GluR2/3 content in spines, we examined the effects of 8-CPT on AMPARdependent miniature excitatory postsynaptic currents (mEPSCs) (Fig. 4) . Incubation of neurons with 8-CPT (50 µM, 1 h) resulted in a robust reduction in the mean amplitudes (34%) and frequency (59%) of AMPAR-mediated mEPSCs (P < 0.05; Fig. 4a ), resulting in a shift in the distribution of mEPSC amplitudes toward smaller values. RNAi knockdown of Epac2 in postsynaptic neurons prevented 8-CPT from reducing the basal mean mEPSC amplitude (Fig. 4a) , confirming the Epac2 specificity of the 8-CPT effect. RNAi expression did not increase the mean amplitude or frequency of AMPAR mEPSCs, consistent with our immunostaining data. Notably, the presence of RNAi in the postsynaptic cell did not affect the 8-CPT-dependent reduction in mEPSC frequency (P < 0.01), suggesting that these effects were caused by activation of presynaptic Epac2, dissociating the pre-and postsynaptic actions of Epac2. Perfusion of neurons with 8-CPT also resulted in a rapid (~10 min), significant reduction of the mean amplitude of AMPAR mEPSCs (P < 0.05; Fig. 4b) , without significantly affecting mean frequency (P > 0.05). For all manipulations, the rise and decay time of mEPSCs were not affected. These results indicate that postsynaptic Epac2 activation rapidly and robustly depresses AMPAR-mediated synaptic transmission by reducing GluR2/3-containing AMPAR content in spines. Activation of Epac2 also caused a reduction in mEPSC frequency, suggesting that it has potential presynaptic effects.
Epac2 mediates dopamine-dependent synaptic remodeling
We next examined the upstream mechanisms regulating Epac2 in cortical pyramidal neurons. Epac2 is one of the few PKA-independent targets of cAMP. In neurons, cAMP levels are elevated by dopamine activation of the D1/D5 G protein-coupled receptor (DAR-D1/D5); in non-neuronal cells, DAR-D1/D5 activation enhances Epac activity. Therefore, we tested whether Rap1 activity in neurons was enhanced by activation of DAR-D1/D5. Incubation of neurons with the D1/D5-specific agonist SKF-38393 (20 µM, 30 min) induced an enhancement of Rap1 activity that was comparable to that caused by 8-CPT (P < 0.05; Fig. 5a ). To determine whether DAR-D1/D5 activation stimulated Rap1 activity in dendrites, we examined the effect of SKF-38393 on B-Raf phosphorylation (Fig. 5b) . Incubation of neurons with SKF-38393 significantly increased B-Raf phosphorylation in situ in dendrites (P = 0.001).
DAR-D1/D5 signaling has not yet been investigated with regards to spine plasticity. Incubation of neurons with SKF-38393 (20 µM, 30 min) caused a reduction in spine areas (P < 0.001; Fig. 5c,d) . In the presence of Epac2 RNAi, the effect of SKF-38393 on dendritic spines was occluded (Fig. 5c,d) ; treatment with SKF-38393 did not affect linear density (Supplementary Fig. 6 ). Furthermore, SKF-38393 caused a significant reduction in the amount of surface GluR2 on spines (P < 0.001; Fig. 5c,e) . This effect required Epac2, 
Epac2 complexes with neuroligins
Neuroligins are a class of synaptic adhesion molecules that modulate synapse morphology and excitatory/inhibitory synapse balance 20 . NL3 and 4 have also been genetically associated with autism 27 . We reasoned that Epac2 may participate in protein complexes with neuroligins. Using co-immunoprecipitation in cortical neurons, we found that NL3 and 1 strongly and specifically interacted with Epac2 (Fig. 6a) . Epac2 also interacted with NL2, albeit more weakly than with NL3 or 1. Epac2 did not interact with N-cadherin, another synaptic adhesion molecule. Reverse co-immunoprecipitation confirmed the interaction of Epac2 with NL1 and 3 (Fig. 6b) . Epac2 immunoprecipitated NL1 and 3, and to a lesser extent NL2, from rat cortex (Fig. 6c) . This interaction was enhanced by 8-CPT (Supplementary Fig. 9 ). Hemagglutinin (HA)-tagged Epac2 immunoprecipitated NL3 or PSD-95 when these proteins were overexpressed in HEK293 cells, suggesting that they are members of a complex (Supplementary Fig. 9 ). Consistent with this, Epac2 colocalized with NL1 and 3 in a large fraction of spine-like structures ( Fig. 6d and Supplementary Fig. 1 ). We hypothesized that neuroligins could potentially recruit Epac2 to the plasma membrane. To test this, we used COS7 cells. When expressed alone, GFP-Epac2 was diffusely distributed in the cytosol, whereas HA-NL3 was found at the plasma membrane (Fig. 6e) . In contrast, when coexpressed with NL3, a fraction of Epac2 was recruited to the plasma membrane (Fig. 6e) . Similarly, overexpression of NL3 enhanced Epac2 localization to the membrane in dendrites (Supplementary Fig. 9 ). We next sought to determine whether Epac2 activation altered Epac2 colocalization with NL3 in neurons. Neurons treated with 8-CPT had more puncta with colocalized Epac2 and NL3 (Fig. 6f) , an effect that was driven by an increased number of Epac2-immunoreactive puncta (Supplementary Fig. 3 ). The number of NL3-positive puncta was not affected (Fig. 6f and Supplementary Fig. 9 ). Because Epac2 translocation to the plasma membrane is associated with its activation 28 , we reasoned that NL3 may activate Epac2. Indeed, coexpression of Epac2 with NL3 robustly enhanced its Rap-GEF activity (P < 0.001; Fig. 6g,h ). Collectively these data suggest that Epac2 and NL1/3 form protein complexes in neurons, NL3 is capable of recruiting Epac2 to the plasma-membrane, Epac2's proximity to NL3 is modulated in parallel with Epac2 activation and NL3 enhances Epac2's Rap-GEF activity.
Disease-associated mutants of Epac2 affect Rap signaling
Four rare coding mutations in Epac2 (M165T, V646F, G706R and T809S) have been genetically associated with autism 17 (Supplementary Fig. 10 ). These variants strictly segregate with autistic family members and are not present in unafflicted individuals. To test whether these mutations affected protein function and synapse morphology, we generated point mutants of the Epac2 protein that corresponded to these variants ( Supplementary  Fig. 10 ). We first examined whether the Epac2 mutations affected its Rap-GEF activity by measuring Rap1-GTP in HEK293 cells transfected with either mutant or wild-type Epac2. The Epac2-V646F mutant impaired the Rap-GEF activity of Epac2 (P = 0.01; Fig. 7a,b) . Because NL3 enhanced Epac2 activity, we examined the effects the Epac2 mutants on NL3-dependent stimulation of Epac2's GEF activity (Fig. 7c,d) . Coexpression of NL3 with Epac2-V646F resulted in reduced Rap activation, similar to the effect of this mutation on basal Rap-GEF activity. Conversely, coexpression of NL3 with Epac2-T809S increased its Rap-GEF activity (P < 0.001).
We next examined the effects of Epac2 mutations on dendritic B-Raf phosphorylation (Fig. 7e,f) . Consistent with our biochemical data, expression 
Disease-associated mutants of Epac2 alter spine morphology
Because they affected protein function, we hypothesized that some of the Epac2 mutations may affect spine morphology. Overexpression of two of the mutants in neurons (28 DIV) affected spine morphology (Fig. 8a,b) . Epac2-V646F caused a significant increase in average spine area (P < 0.001; Fig. 8b ). Epac2-T809S increased the spine average linear density (P < 0.001).
To gain insight into the potential mechanisms underlying the spine morphological changes, we examined the effects of Epac2 mutations on the average intensity and number of PSD-95 immunofluorescent puncta in dendrites (Fig. 8c,d) . Overexpression of PSD-95 has previously been shown to induce synaptogenesis and increased spine number 7 . Expression of Epac2-V646F increased the average PSD-95 immunofluorescence intensity in individual puncta, consistent with its effect on spine size (P < 0.001). Conversely, Epac2-T809S increased the number of PSD-95 clusters along dendrites, consistent with its effect on spine density (P < 0.001). These data indicate that the Epac2-V646F and Epac2-T809S mutants affect Epac2 protein function and dendritic spine morphology.
DISCUSSION
Our results identify a previously unknown mechanism that promotes the dynamic remodeling of spiny synapses on cortical pyramidal neurons, actively destabilizing spines by promoting their shrinkage and increasing their motility, as well as removing GluR2/3-containing AMPAR and depressing glutamatergic transmission (Supplementary Fig. 11 ). Similar effects were caused by the stimulation of DAR-D1/D5s; these effects were prevented by postsynaptic knockdown of Epac2. Notably, two disease-associated Epac2 mutations affected protein function and dendritic Rap signaling and their expression in pyramidal neurons affected spine morphology and PSD-95 clustering. Because synapse dynamic remodeling is important in the maturation, refinement and plasticity of brain circuits, and may malfunction in some disorders, our results suggest that Epac2 is involved in normal and pathological brain plasticity.
Epac2 activation enhances spine dynamic remodeling, consisting of spine shrinkage, turnover, head morphing and reduced overlap with presynaptic release sites (Supplementary Fig. 11) . Conversely, Epac2 inactivation causes spine enlargement and stabilization. a r t I C l e S However, Epac2 does not promote synapse elimination. Spine shrinkage occurs during various forms of brain plasticity, including hippocampal LTD 3, 4 . Small, thin and highly dynamic spines are important for the development, refinement and experience-dependent plasticity of cortical neuronal circuits 1, 5 . Although filopodia in young neurons are highly motile, spines with mature morphologies are more stable. Even in the mature cortex, however, there is a steady state of spine morphing and turnover, modulated by physiological stimuli such as experience 1, 2 . Epac2 may promote the dynamic remodeling of such otherwise stable spines. Few molecules, on activation, are known to promote spine shrinkage and increased motility without elimination 7 (Supplementary Discussion).
Epac2 activation caused a reduction in the amount of AMPARs in spines and reduced the amplitude and frequency of AMPAR-mediated mEPSCs, indicating that Epac2 also depresses glutamatergic transmission. Epac2 specifically regulates GluR2/3, probably as a result of the participation of Epac2, along with PSD-95, in protein complexes with GluR2/3. In these complexes, Epac2 can respond to stimuli and activate Rap, which in turn diffuses to nearby GluR2/3 receptors and triggers their internalization. Our data suggest that Epac2 activation selectively removes GluR2/3 subunit-containing AMPARs from synapses; the remaining synaptic AMPARs may consist of a larger fraction of GluR1/ GluR2-containing receptors and fewer GluR2/GluR3-containing receptors. As GluR2/3 is removed from spines, the total amount of functional AMPARs is reduced, leading to reduced AMPAR mEPSC amplitudes.
Epac2-dependent changes in synaptic GluR2/3 content may contribute to several types of plasticity 29, 30 . A range of effects of 8-CPT incubation have been reported in different neuronal preparations. Short-term and transient presynaptic potentiation has been reported in invertebrate neuromuscular junctions 31, 32 , the calyx of Held, and in young hippocampal and cortical neurons 33 (Supplementary Discussion). Postsynaptically, from 8-CPT responsiveness, recent studies found PACAP-, protein synthesis-and ERK-dependent LTD 34 , and facilitation of βAR-, HFS-, protein synthesis-and ERK-dependent LTP, without affecting LTP induction 35 . One potential explanation for these diverging effects is that transient destabilization could make synapses more receptive to subsequent activity-dependent potentiating or depressing stimuli, leading to LTP or LTD, respectively 12 . Modulation of synapses by Epac proteins may also affect cognitive functions and behavior. Epac and PKA are jointly required for hippocampal memory retrieval 36 , and Epac activation with 8-CPT rescued psychiatric disease-related deficits in sensory motor gating and memory caused by overactivation of Gα s signaling 37 .
cAMP signaling is important in synaptic plasticity 38 , learning, memory, psychiatric disease and drug addiction. Most previous work on cAMP signaling in pyramidal neurons has focused on its actions through PKA. However, several studies have reported that postsynaptic cAMP-dependent, but PKA-independent, mechanisms induce LTD, depress basal synaptic transmission and reverse potentiation 39 . In dendrites, cAMP is produced on activation of G s -coupled receptors, such as D1-like receptors. Little is known about the mechanisms of regulation of spine morphology by dopamine signaling. We found that DAR-D1/D5 activation stimulated dendritic Rap signaling, causing Epac2-dependent spine shrinkage and GluR2 removal. In cortical pyramidal neurons, DAR-D1/D5s a r t I C l e S control plasticity bidirectionally, inducing both LTD and LTP 40, 41 . Dopamine also facilitates LTD in rat prefrontal cortex 42 , and application of cAMP under specific conditions depresses synaptic transmission 38, 43 . Epac activation rescues Gα s signaling overactivation-induced deficits in animals 37 . Other studies have reported dopamine-and D1-dependent enhancement of synaptic transmission 44 . The specific conditions under which dopamine signaling promotes potentiation or depression are not completely understood. Our data indicate that Epac2 mediates neuromodulation by DAR-D1/D5 and link dopamine signaling with synapse structural remodeling. Epac2 participated in protein complexes with NL1 and 3, and these proteins showed extensive colocalization in dendrites. Our data suggest that NL3 recruits Epac2 to the plasma membrane and enhances its Rap-GEF activity. Enhanced Epac2 activity promoted spine shrinkage and increased spine dynamics. Neuroligins are synaptic adhesion molecules that have previously been shown to promote synapse formation and maturation [19] [20] [21] . Such seemingly opposite functions are also simultaneously performed by another class of synaptic adhesion molecules, ephrinB and EphB, which promote filopodia motility and motility-dependent synaptogenesis 45 . As suggested for EphB 45 , neuroligin-Epac2-Rap signaling may promote local sampling of the presynaptic environment through increased spine motility and may also provide transcellular interaction between the dynamic spines and newly contacted presynaptic terminals.
Neuroligins and their ligands neurexins are associated with autism spectrum disorders (ASD). Chromosomal regions of NLGN3, NLGN4 and NRXN1 have been implicated in ASD 27, 46 , but rare mutations in these genes do not account for the strong association of their loci with ASD. Mutations in NLGN3 and NLGN4 that have been detected in autistic individuals encode proteins with altered function 46 . Interaction with neuroligins places Epac2 in functional proximity to proteins that have previously been implicated in ASD, suggesting that it participates in the same synaptic signaling network.
A screen of autistic individuals identified four rare nonsynonymous variants in the EPAC2 gene 17 . We found that two of these mutations affected protein function, signaling and synapse remodeling. Specifically, Epac2-V646F impaired the basal GEF activity and Rap-dependent signaling in dendrites, leading to larger spines and larger PSD-95 clusters (Supplementary Fig. 11 ). These effects are similar to those caused by Epac2 knockdown or Epac2-∆GEF and can be explained by reduced GEF activity. On the other hand, the Epac2-T809S was more responsive to NL3-dependent enhancement of its GEF activity, leading to increased Rap signaling in dendrites (Supplementary Fig. 11 ). Its neuronal expression increased spine density, probably as a result of an increased responsiveness to NL3-dependent enhancement of its GEF activity and increased clustering of PSD-95, a molecule with established synaptogenic properties. Although the other two mutations did not affect any of the tested parameters, this does not exclude potential effects on other neuronal properties or interaction with other unknown genetic or environmental factors. Aberrant synaptic connectivity is thought to occur in autism and comorbid diseases, including fragile-X, and increased cortical dendritic spine density has been reported in some individuals with autism 6 . Understanding Epac2 function in spines may therefore shed light on normal and disease-associated spine plasticity. a r t I C l e S METhODS Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
